Matches in SemOpenAlex for { <https://semopenalex.org/work/W2191699159> ?p ?o ?g. }
- W2191699159 abstract "Natural compounds have been demonstrated to lower breast cancer risk and sensitize tumor cells to anticancer therapies. Recently, we demonstrated that vernodalin (the active constituent of the medicinal herb Centratherum anthelminticum seeds) induces apoptosis in breast cancer cell-lines. The aim of this work was to gain an insight into the underlying anticancer mechanism of vernodalin using in vitro and in vivo model. Vernodalin was isolated through the bioassay guided fractionation from the seeds. The protein expression of p-Akt, PI3K, FOXO3a, Bim, p27kip1, cyclinD1, and cyclinE was examined by the Western blot analysis. Immunoprecipitation assays were performed to analyse Akt kinase activity. Small interfering RNA (siRNA) was used to study the role of FOXO3a upregulation and their targets during vernodalin treatment. Immunofluorescence, subcellular localisation of FOXO3a by Western blot was performed to analyse FOXO3a localisation in nucleus of breast cancer cells. Immunohistochemical analysis of PCNA, Ki67, p27kip1, FOXO3a and p-FOXO3a in the LA7-induced mammary gland tumor model was performed. Our results showed that vernodalin regulates cancer cell apoptosis through activation of FOXO transcription factors and its downstream targets (Bim, p27Kip1, p21Waf1/cip1, cyclin D1, cyclin E) as examined by Western blots. Furthermore, we showed that FOXO3a/PI3K-Akt played a significant role in vernodalin induced apoptosis in breast cancer cells. Immunoprecipitation assays showed Akt kinase activity was downregulated. Immunofluorescence, subcellular fractionation and Western blot showed FOXO3a accumulation in the nucleus of breast cancer cells after vernodalin treatment. Silencing of FOXO3a protected breast cancer cells against vernodalin induced apoptosis. The anti-tumor action of vernodalin was further confirmed by examining cell proliferative markers, PCNA and Ki67 in the LA7-induced mammary gland tumor model. We also corroborated our findings in vivo by showing upregulation of p27Kip1, FOXO3a and decrease in the p-FOXO3a level in vernodalin-treated breast tumor tissue. Our results suggest that PI3K-Akt/FOXOa pathway is a critical mediator of vernodalin-induced cytotoxicity and this compound could be further developed as a potential chemopreventive or chemotherapeutic agent for breast cancer therapy." @default.
- W2191699159 created "2016-06-24" @default.
- W2191699159 creator A5019325995 @default.
- W2191699159 creator A5028635739 @default.
- W2191699159 creator A5042503966 @default.
- W2191699159 creator A5044842808 @default.
- W2191699159 creator A5046726096 @default.
- W2191699159 creator A5053135777 @default.
- W2191699159 creator A5076805273 @default.
- W2191699159 creator A5089764779 @default.
- W2191699159 date "2015-12-01" @default.
- W2191699159 modified "2023-10-15" @default.
- W2191699159 title "Forkhead Box Transcription Factor (FOXO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo" @default.
- W2191699159 cites W1515573227 @default.
- W2191699159 cites W1628841297 @default.
- W2191699159 cites W1967268536 @default.
- W2191699159 cites W1967570571 @default.
- W2191699159 cites W1968226282 @default.
- W2191699159 cites W1978221635 @default.
- W2191699159 cites W1982088633 @default.
- W2191699159 cites W1983320405 @default.
- W2191699159 cites W1986464708 @default.
- W2191699159 cites W1986896225 @default.
- W2191699159 cites W2003564950 @default.
- W2191699159 cites W2003879233 @default.
- W2191699159 cites W2011785467 @default.
- W2191699159 cites W2012339210 @default.
- W2191699159 cites W2017611872 @default.
- W2191699159 cites W2019365183 @default.
- W2191699159 cites W2021092136 @default.
- W2191699159 cites W2021505095 @default.
- W2191699159 cites W2026316461 @default.
- W2191699159 cites W2029067192 @default.
- W2191699159 cites W2032427485 @default.
- W2191699159 cites W2037517052 @default.
- W2191699159 cites W2039985307 @default.
- W2191699159 cites W2043402160 @default.
- W2191699159 cites W2043865307 @default.
- W2191699159 cites W2046919270 @default.
- W2191699159 cites W2048922769 @default.
- W2191699159 cites W2049562411 @default.
- W2191699159 cites W2051107237 @default.
- W2191699159 cites W2057402345 @default.
- W2191699159 cites W2058344998 @default.
- W2191699159 cites W2059144308 @default.
- W2191699159 cites W2062629127 @default.
- W2191699159 cites W2067403798 @default.
- W2191699159 cites W2073482997 @default.
- W2191699159 cites W2074918415 @default.
- W2191699159 cites W2076103389 @default.
- W2191699159 cites W2079852092 @default.
- W2191699159 cites W2083347540 @default.
- W2191699159 cites W2087861588 @default.
- W2191699159 cites W2088442622 @default.
- W2191699159 cites W2091327765 @default.
- W2191699159 cites W2091616261 @default.
- W2191699159 cites W2091798601 @default.
- W2191699159 cites W2106787323 @default.
- W2191699159 cites W2110354540 @default.
- W2191699159 cites W2112132009 @default.
- W2191699159 cites W2112182413 @default.
- W2191699159 cites W2116361358 @default.
- W2191699159 cites W2117692326 @default.
- W2191699159 cites W2121619780 @default.
- W2191699159 cites W2129566023 @default.
- W2191699159 cites W2137035181 @default.
- W2191699159 cites W2141228362 @default.
- W2191699159 cites W2141861077 @default.
- W2191699159 cites W2143838754 @default.
- W2191699159 cites W2146983373 @default.
- W2191699159 cites W2154041756 @default.
- W2191699159 cites W2156563694 @default.
- W2191699159 cites W2161551303 @default.
- W2191699159 cites W2161817637 @default.
- W2191699159 cites W2166529745 @default.
- W2191699159 cites W2167352512 @default.
- W2191699159 cites W2170564280 @default.
- W2191699159 cites W2172184755 @default.
- W2191699159 cites W2172228232 @default.
- W2191699159 cites W2388163742 @default.
- W2191699159 cites W2411429033 @default.
- W2191699159 cites W2435919297 @default.
- W2191699159 cites W3128877721 @default.
- W2191699159 cites W4205406915 @default.
- W2191699159 cites W4229704949 @default.
- W2191699159 cites W4235221123 @default.
- W2191699159 cites W4244685317 @default.
- W2191699159 cites W4362060345 @default.
- W2191699159 cites W1555219115 @default.
- W2191699159 doi "https://doi.org/10.1186/s13046-015-0266-y" @default.
- W2191699159 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4672543" @default.
- W2191699159 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26643256" @default.
- W2191699159 hasPublicationYear "2015" @default.
- W2191699159 type Work @default.
- W2191699159 sameAs 2191699159 @default.
- W2191699159 citedByCount "31" @default.
- W2191699159 countsByYear W21916991592016 @default.
- W2191699159 countsByYear W21916991592017 @default.
- W2191699159 countsByYear W21916991592018 @default.
- W2191699159 countsByYear W21916991592019 @default.